Vomiting News and Research

RSS

Vomiting is the process the body uses to eject some or all of the contents of the stomach through the mouth.

Savella - Fibromyalgia treatment approved by FDA

Forest Laboratories, Inc. and Cypress Bioscience, Inc. have announced that Savella (milnacipran HCl), a selective serotonin and norepinephrine dual reuptake inhibitor, was approved by the U.S. Food and Drug Administration (FDA) for the management of fibromyalgia.

19 Jan 2009

New mouse model for peanut allergy

Chicago researchers report the development of a new mouse model for food allergy that mimics symptoms generated during a human allergic reaction to peanuts.

12 Jan 2009

Discovery of gene that increases susceptibility to Crohn's disease

Researchers at McGill University, the Research Institute of the McGill University Health Centre (RI MUHC) and the McGill University and Génome Québec Innovation Centre, along with colleagues at other Canadian and Belgian institutions, have discovered DNA variations in a gene that increases susceptibility to developing Crohn's disease.

8 Jan 2009

Phase III studies of EXPAREL (DepoBupivacaine) from Pacira complete enrollment

Pacira Pharmaceuticals, Inc., an acute care specialty pharmaceutical company, announced today that enrollment has been completed in two pivotal Phase III SIMPLE trials to evaluate the safety and efficacy of a single intraoperative administration of EXPAREL(TM) (DepoBupivacaine) for prolonged postoperative analgesia.

6 Jan 2009

Genetic mutation causes familial susceptibility for degenerative brain disease acute necrotizing encephalopathy

Mutation of a gene that helps proteins migrate in and out of the cell's genetic command center - the nucleus - puts some families at higher risk for the degenerative brain disease acute necrotizing encephalopathy (ANE).

6 Jan 2009

Bulimia linked to brain circuit abnormalities

Scientists in the U.S. are suggesting that women who suffer from bulimia nervosa may have an abnormality in the brain circuit.

6 Jan 2009

Phase 3 trial begins for Gammagard liquid plus rHuPH20 in primary immunodeficiency patients

Baxter International Inc. and Halozyme Therapeutics, Inc. gas announced the start of a Phase 3 clinical trial of Baxter's Gammagard Liquid [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze Technology) for the treatment of primary immunodeficiency (PID).

From Baxter International Inc. 5 Jan 2009

Frontostriatal brain circuits play role in bulimia nervosa in women

Women with bulimia nervosa appear to respond more impulsively during psychological testing than those without eating disorders, and brain scans show differences in areas responsible for regulating behavior, according to a report in the January issue of Archives of General Psychiatry , one of the JAMA/Archives journals.

5 Jan 2009

Dengue fever outbreak now in Townsville

While health authorities continue to battle to contain an outbreak of Dengue fever in Cairns in north Queensland, further down the coast an outbreak has now been reported in Townsville.

5 Jan 2009

Brits battling to cope with 'killer' Australian flu strain

As doctors and hospitals in the UK struggle to deal with a flu epidemic, Brits are being warned that the current outbreak is expected to intensify in the new year as the potentially fatal Australian strain of influenza spreads across the country.

30 Dec 2008

Drink sensibly tonight and remember - there's no such thing as a hangover cure!

Across the world New Year's Eve revellers are being urged to drink responsibly in bringing in 2009.

30 Dec 2008

Contact with plants shown to directly benefit patient's health

Contact with nature has long been suspected to increase positive feelings, reduce stress, and provide distraction from the pain associated with recovery from surgery.

30 Dec 2008

Man dies from flesh-eating disease

A rare flesh-eating disease has claimed the life of a man in Britain. The 60 year old man Tony Williamson died days after a flesh-eating disease spread through his body from a small cut on the inside of his right arm.

28 Dec 2008

AstraZeneca submits sNDA for NEXIUM (esomeprazole magnesium)

AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for NEXIUM(R) (esomeprazole magnesium) to seek approval for the short-term (up to 6 weeks) treatment of gastroesophageal reflux disease (GERD) in pediatric patients ages 0 to 1 year old.

21 Dec 2008

FDA approves Gleevec (imatinib mesylate) to prevent gastrointestinal stromal tumor

The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.

21 Dec 2008

FDA approves Mozobil (plerixafor) for multiple myeloma or non-Hodgkin's lymphomas

The U.S. Food and Drug Administration has approved Mozobil (plerixafor), a drug that helps increase the number of blood stem cells for bone marrow transplantation in patients with certain forms of blood cancer.

18 Dec 2008

Human parechovirus may trigger type 1 diabetes

Human parechovirus is a harmless virus which is encountered by most infants and displays few symptoms.

18 Dec 2008

Expert says gross over-reaction to peanuts to blame for 'nut hysteria'

A Professor at Harvard Medical School suggests many people today are over-reacting to the threat of peanut allergies in children.

17 Dec 2008

New form of cognitive behavioural therapy shows potential to treat majority of cases of eating disorders

Wellcome Trust researchers have developed a new form of psychotherapy that has been shown to have the potential to treat more than eight out of ten cases of eating disorders in adults, a study out today reports.

15 Dec 2008

Exparel (DepoBupivacaine) shows promise in hernia repair

A Phase II trial of a single intraoperative administration of Exparel (DepoBupivacaine) resulted in significantly reduced pain with activity in the first 8 to 24 hours following surgery, when pain is generally greatest, compared to conventional treatment.

14 Dec 2008